Health Condition 1: null- Ureteric and renal calculi Health Condition 2: N209- Urinary calculus, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a.Patients planned for SWL b.Single radiopaque renal 6 to 24 mm or c.Single ureteral 6 to 15 mm calculus
Exclusion criteria
Exclusion criteria: a.Radiolucent calculus b.Past unsuccessful SWL c.Renal impairment (creatinine greater than 1.5 mg/dl) d.Radiolucent calculus e. Urinary tract infection f. On calcium channel blockers, nitrates, alpha1-adrenergic antagonists or PDE5 inhibitors g. Congenital urinary tract anomalies h. Contraindication to PDE5 inhibitors or alpha blockers i. Children
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Successful stone clearanceTimepoint: Stone-free status or presence of clinically insignificant asymptomatic residual fragments remaining in the kidney of less than 3 mm at 1 month or earlier. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expulsion timeTimepoint: Duration in days - From day of start of study to stone clearance;Side effects of tamsulosin and tadafilTimepoint: Tamsulosin - dizziness, drowsiness, weakness; nausea, dyspepsia, diarrhea; headache, chest pain; abnormal ejaculation, back pain; blurred vision; tooth problems; fever, chills, body aches, flu symptoms. Tadalafil - redness or warmth in face, neck, or chest; Flu symptoms, headache; memory problems; diarrhea, dyspepsia or muscular pain, back pain.;SteinstrasseTimepoint: Incidence of Steinstrasse and its eventual clearance;Analgesic requirementTimepoint: Amount of analgesic ingested for pain episodes, pain episodes requiring hospital visit | — |
Countries
India
Contacts
Christian Medical College and Hospital, Vellore